Video commentary with UBS Chief Investment Office (CIO) analysts
Genetic therapies use genes and cells to treat serious diseases. The technology represents a paradigm shift in medical care compared to traditional drug treatment, which usually just slows disease progression.
Speaker: Lachlan Towart, UBS CIO equity analyst
Released date: June 11, 2020